Related by context. All words. (Click for frequent words.) 69 Benign Prostatic Hyperplasia 69 Pooled Analysis 68 Complicated Skin 68 Resistant Hypertension 68 Overactive Bladder 67 Chronic Hepatitis B 67 Predict Risk 67 Phase 2b Clinical Trial 67 Renal Cell Carcinoma 66 Relapsing Remitting Multiple Sclerosis 66 Oral Fingolimod 66 Rheumatoid Arthritis Patients 66 Prophylactic Treatment 66 Combination REOLYSIN R 66 Lowers Risk 66 Improve Survival 66 Advanced Melanoma 66 Cardiovascular Outcomes 66 Treatment Shows Promise 66 Thromboembolism 66 Patients Treated With 66 Meets Primary Endpoint 66 Controlled Trial 66 Randomized Study 65 Phase III Clinical Trial 65 Improves Outcomes 65 Ischemic Stroke 65 Atypical Hemolytic Uremic Syndrome 65 Chronic Heart Failure 65 Knee Osteoarthritis 65 Randomized Trials 65 Allergic Rhinitis 65 Malignant Melanoma 65 Elderly Patients 65 Polyneuropathy 65 Subgroup Analysis 65 Prolongs Survival 65 Relapsed Multiple Myeloma 65 Slow Progression 65 Hormone Refractory Prostate Cancer 65 Clinical Outcome 65 Chronic Myeloid Leukemia 65 Shows Promise Against 65 Meta Analysis 65 Ischemic 65 Clinical Trial Results 65 Systemic Sclerosis 65 Cholesterol Lowering Drug 64 Postmenopausal Women 64 Multicenter Randomized 64 Diabetic Macular Edema 64 Enlarged Prostate 64 Neovascular Age Related Macular 64 Adjuvant Chemotherapy 64 Subtypes 64 Genes Linked 64 Lupus Nephritis 64 Therapy Shows Promise 64 Statin Therapy 64 Randomized Clinical Trials 64 Combination Treatment 64 Phase IIb Trial 64 Colorectal Adenomas 64 Hepatocellular Carcinoma 64 Serious Infections 64 Randomized Controlled Trials 64 Sleep Disturbances 64 Investigational Treatment 64 Trial Evaluating 64 Patients Receiving 64 Completes Enrollment 64 Fracture Risk 64 Naive Patients 64 Relapsing Multiple Sclerosis 64 Nicotine Vaccine 64 Acute Ischemic Stroke 64 Gene Linked 64 Osteoporotic 64 Treatment Naïve 63 Metastatic Colorectal Cancer 63 Demonstrates Positive 63 See CLINICAL PHARMACOLOGY 63 Single Dose 63 Diabetic Neuropathic Pain 63 Patient Enrollment 63 Metastatic Prostate Cancer 63 Novel Oral 63 Improves Survival 63 Improve Outcomes 63 Shows Efficacy 63 Tyrosine Kinase Inhibitor 63 Carcinomas 63 Female Stress Urinary 63 Generalized Anxiety Disorder 63 Often Misdiagnosed 63 Prospective Cohort Study 63 Chronic Liver Disease 63 Randomized Double blind 63 Shows Promising 63 Previously Treated 63 Slows Progression 63 Skin Structure Infections 63 Vertebral Compression Fractures 63 headache abdominal pain 63 Atopic Dermatitis 63 Carotid Stenting 63 Genes Predict 63 Treatment Reduces 63 Acute Coronary 63 Phase 2b Trial 63 Generalized Anxiety Disorder GAD 63 Venous Thrombosis 63 Autoimmune Diseases 63 Phase 2a Clinical Trial 63 Critical Limb Ischemia CLI 63 Phase 2a Trial 63 Gastric Cancer 63 Potentially Fatal 63 induce orthostatic hypotension 63 Demonstrates Sustained 63 Chronic Constipation 63 Interferon Beta 63 Metastatic Melanoma 63 Hepatitis C Virus 63 Venous Thromboembolism 63 Significantly Improved 63 Chronic Bronchitis 63 Helps Predict 63 Occlusive Disease 63 Severe Sepsis 63 Phase III Trials 63 Chronic Sinusitis 63 Fungal Infections 63 Relapsed Refractory 63 chills fever headache 63 Completes Patient Enrollment 62 Acute Exacerbations 62 Proves Effective 62 Study Evaluating 62 Psychiatric Disorders 62 Non Alcoholic Steatohepatitis 62 Adjunctive 62 Randomised Trial 62 ST Elevation Myocardial 62 Files IND 62 headache nasopharyngitis 62 Bone Metastases 62 Hypertensive Patients 62 Immunomedics Announces 62 Chronic Prostatitis 62 Drug Candidate 62 Drug Shows Promise 62 NASH Huntington 62 Non Alcoholic Fatty 62 Schizoaffective Disorder 62 Pivotal Study 62 Clostridium difficile Infection 62 Double Blind Placebo 62 Chronic Hepatitis C 62 Liver Failure 62 Treatment Experienced 62 Gene Mutation 62 Demonstrates Efficacy 62 Migraine Pain 62 Cerebril TM 62 Adjuvant Treatment 62 Epidermal Growth Factor Receptor 62 PEGINTRON TM 62 reflux disease GERD 62 Therapy Improves 62 Chronic Inflammatory 62 HER2 Positive 62 Chronic HCV 62 Effectively Treats 62 Successfully Treats 62 Tigecycline 62 Patients Undergoing 62 Patients Treated 62 Treating Chronic 62 First Patient Dosed 62 Benign prostatic hyperplasia BPH 62 Hepatic Encephalopathy 62 Refractory Hodgkin Lymphoma 62 Drug Resistant 62 Heart Failure Patients 62 Poorly Controlled 62 NMDA Receptor 62 Drug Prevents 62 Surgical Procedures 62 FDA APPROVES 62 Inflammatory Diseases 62 Vaccine Candidate 62 Help Predict 62 Transdermal Patch 62 Myelodysplastic Syndromes 62 Localized Prostate Cancer 62 Left Ventricular Hypertrophy 62 Mouse Model 62 Randomized Controlled Trial 62 Virus Linked 62 Antitumor Activity 62 Prostate Cancer Patients 62 Antipsychotic Medications 62 Drug Combo 62 Initiates Clinical Trials 62 Reflux Disease 62 CYT# potent vascular disrupting 62 Renal Impairment 62 Controlled Study 62 Receives Orphan Drug Designation 62 Hypercholesterolemia 62 Renal Artery 62 Soft Tissue Sarcoma 62 Iron Overload 62 Breast Cancers 62 Dupuytren Contracture 62 Patients Enrolled 62 Inhaled Corticosteroids 62 Increases Risk 62 Neovascular AMD 62 Viral Infections 62 Genes Identified 62 Juvenile Idiopathic Arthritis 62 Irritable Bowel 62 Protein Linked 62 Chronic Pelvic Pain 62 Observational Study 62 Decompensated Heart Failure 62 Secondary Hyperparathyroidism 62 Pivotal Clinical Trial 62 vitreous floaters 62 Cognitive Problems 62 arthritis PsA 62 Newly Diagnosed 62 Virus Infection 61 Leukemias 61 Vitrasert R 61 Beneficial Effects 61 Phase III Trial 61 Seasonal Allergic Rhinitis 61 Myeloma Patients 61 dual endothelin receptor antagonist 61 Improved Survival 61 Gene Mutation Linked 61 Pulmonary Arterial Hypertension 61 JAK Inhibitor 61 Myocardial Infarction Study 61 Iron Deficiency 61 First Patient Treated 61 Achieves Primary Endpoint 61 Bare Metal Stents 61 Effective Treatments 61 ST Segment Elevation 61 Community Acquired Pneumonia 61 Rheumatoid Arthritis Drug 61 Male Infertility 61 Prevent Heart 61 Postmenopausal 61 Disease Progression 61 Intra Arterial 61 Reduces Pain 61 Gastrointestinal Stromal Tumors 61 Pediatric Patients 61 Premenopausal Women 61 Peripheral Arterial 61 Lymphocytic 61 Smoking Linked 61 Unstable Angina 61 Hepatitis C Patients 61 Peginterferon alfa 2b 61 Anti Tumor Activity 61 Bronchiectasis 61 Proven Effective 61 Significantly Reduces 61 Levels Linked 61 Endometrial Cancer 61 Stomach Cancer 61 Telithromycin 61 Targeted Therapies 61 Vaccine Protects Against 61 atypical Hemolytic Uremic Syndrome 61 HER2 Positive Breast Cancer 61 Respiratory Distress 61 Novel Therapeutic 61 Investigational Agent 61 Invasive Fungal Infections 61 Paroxysmal Nocturnal Hemoglobinuria PNH 61 Chronic Fatigue Syndrome CFS 61 Previously Untreated 61 Treating Heart Failure 61 Premature Infants 61 Survival Benefit 61 Diabetic Neuropathy 61 Treated Patients 61 Clot Busting 61 Signaling Pathway 61 Develop Novel 61 overactive bladder syndrome 61 Acute Coronary Syndromes 61 Pivotal Phase III 61 Total Knee Arthroplasty 61 Statistically Significant 61 Androgen Deprivation Therapy 61 Bosutinib 61 Safinamide 61 Breast Cancer Recurrence 61 Demonstrate Significant 61 Irritable Bowel Syndrome IBS 61 Efficacy Trial 61 Phase IIb Clinical Trial 61 Monotherapy 61 Critical Limb Ischemia 61 Acute Renal Failure 61 Clinically Significant 61 Tumor Growth 61 Data Suggest 61 toenail onychomycosis 61 Beta Blocker 61 Prospective Randomized 61 NAVISTAR R 61 Rheumatoid Arthritis RA 61 R lenalidomide 61 SPRYCEL ® 61 ACER paper 61 First Patient Enrolled 61 Fewer Side Effects 61 Significantly Improves 61 Topical Treatment 61 Advanced Ovarian Cancer 61 Stent Implantation 61 CP CPPS 61 Prostatic 61 Hypertrophic 61 Renal Cancer 61 Bacterial Infections 61 Study Demonstrates 61 diarrhea headache nausea 61 Hemorrhagic 61 Orally Active 61 Cardiotoxicity 61 Esophagitis 61 Shown Effective 61 Osteoporosis Drugs 61 Research www. elsevier.com 61 Advanced Colorectal Cancer 61 Migraine Headaches 61 Reduced Risk 61 THAT ARE DIFFICULT TO 61 Genetic Markers 61 Systemic lupus erythematosus SLE 61 Cognitive Deficits 61 Test Detects 61 Gene Variant 61 Lupus Drug 61 Lung Cancer Patients 61 myocardial infarction ventricular fibrillation 61 Cognitive Impairment 61 Malignant Glioma 61 Intracranial Aneurysms 61 Skin Disorders 61 Cardiac Resynchronization 60 Preclinical Study 60 Lipodystrophy 60 Ischaemic 60 Cognitive Decline 60 Gastroesophageal Reflux Disease 60 neuromuscular spasm 60 B Cell Malignancies 60 Post Operative 60 Desvenlafaxine Succinate 60 Sangamo BioSciences Announces 60 Initiates Clinical Trial 60 Hospital Acquired Pneumonia 60 Eye Diseases 60 Preclinical Data 60 Nymox NX 60 Gastric Ulcers 60 Placebo Controlled Trial 60 nausea vomiting headache 60 Mitral Regurgitation 60 Fondaparinux 60 Chronic Insomnia 60 Interferon Alpha 60 Chronic Lung 60 TNF Blockers 60 Antipsychotic 60 Thromboembolic 60 INTEGRILIN R 60 Oral Calcitonin 60 Nebulized 60 Unfractionated Heparin 60 Fibromyalgia Pain 60 Cholesterol Levels SPARCL 60 Infected Patients 60 Pivotal Trials 60 Stem Cell Treatment 60 Multicenter Study 60 nasopharyngitis headache 60 Oral Anticoagulant 60 Reduces Mortality 60 Confirms Efficacy 60 Hyperuricemia 60 Nilotinib 60 Neoplasms 60 Bone Fracture 60 Severe Asthma 60 FDA Approves Drug 60 Catheter Ablation 60 Study Evaluates 60 Randomized Double Blind Placebo 60 Appears Safe 60 Inflammatory Arthritis 60 Acute Myocardial Infarction 60 STELARA TM 60 Respond Differently 60 Cervical Disease 60 relapsing remitting MS RRMS 60 Hyperparathyroidism 60 Initiate Clinical Trial 60 treat benign prostatic 60 Clinical Trial Evaluating 60 Showed Significant 60 Anthracycline 60 Randomized Phase 60 Cervical Dysplasia 60 Aggressive Prostate Cancer 60 II Clinical Trial 60 Vaccine Adjuvant 60 Long Term Efficacy 60 ACTEMRA TM 60 NICE Recommends 60 cytomegalovirus infection 60 Adjunctive Therapy 60 Non Responders 60 Ventricular Arrhythmias 60 Bone Fractures 60 Surgical Treatment 60 Tocilizumab 60 CYP#A# CYP#D# 60 Hormone Receptor Positive 60 Refractory Angina 60 Pegylated Interferon 60 Initiates Dosing 60 Antifungals 60 MKC# MT 60 Bazedoxifene 60 Immune Responses 60 Invasive Breast Cancer 60 Demonstrated Significant 60 RNAi Therapeutics 60 LHRH receptor positive 60 Stress Incontinence 60 bone marrow reticulin deposition 60 Mg Uk 60 diarrhea fatigue asthenia 60 Epilepsy Drug 60 hyperphenylalaninemia HPA due 60 Orphan Status 60 Demonstrates Significant 60 Physician Insights 60 Myelofibrosis 60 Postmenopausal Osteoporosis 60 Telik Announces 60 Phase III Pivotal Trial 60 Chemoradiation 60 evaluating tivozanib 60 Treatment Resistant 60 External Beam 60 Successfully Treated 60 By JENNIFER LEARN 60 Inflammatory Markers 60 Prolongs Life 60 Lung Cancer Survival 60 TNF Tumor Necrosis Factor 60 Lung Cancers 60 Female Sexual Arousal 60 Metastatic Renal Cell Carcinoma 60 Gum Disease 60 Preterm Delivery 60 non alcoholic steatohepatitis 60 Colorectal Cancers 60 Study Identifies 60 familial amyloidotic polyneuropathy FAP 60 REMINDER ORLive Presents 60 Cancer Treatments 60 Randomized Double Blind 60 Lower Urinary Tract 60 Respiratory Syncytial Virus RSV 60 Hyperlipidemia 60 Autoimmune Disease 60 IN PATIENTS WITH 60 Amigal TM 60 Monoclonal Antibody 60 oropharyngeal candidiasis OPC 60 Nonalcoholic Fatty Liver Disease 60 Skeletal Muscle 60 dermatologic reactions 60 Central Retinal Vein 60 Hepatitis C Genotype 60 Eculizumab 60 imipramine Tofranil 60 Systemic Juvenile Idiopathic 60 Patients Suffering 60 Valvular Heart Disease 60 included exfoliative dermatitis 60 Placebo Controlled 60 Platelet Inhibition 60 CYP#A# substrate 60 Combo Therapy 60 stable angina pectoris 60 Diabetic Patients 60 ELADUR ™ 60 JAK2 Inhibitor 60 acetonide FA 60 Microplasmin 60 Investigational Drug 60 Viral Infection 60 diarrhea predominant irritable 60 Thoracic Aortic Aneurysms 60 Obesity Linked 60 ALN HPN 60 Submits NDA 60 Chronic Rhinosinusitis 60 Initiates Enrollment 60 TRANSDUR ™ 60 Reminyl galantamine 60 BENLYSTA TM 60 Cardiovascular Events 60 Reduces Risk 60 Combination Therapy 60 Hsp# Inhibitor 60 DG# compounds targeting 60 Stent Restenosis 60 Bone Marrow Cells 60 arterial thromboembolic 60 bronchospasm dizziness headache 60 PEGylated anti 60 Antiviral Therapy 60 Successfully Completes Phase 59 Novel Treatments 59 Genetic Variant 59 Initiates Phase III 59 Intracerebral 59 Brain Metastases 59 Advanced Prostate Cancer 59 Symptom Relief 59 Angioedema 59 hypertrichosis occurred 59 Randomized Controlled 59 Pivotal Phase 59 pneumocystis pneumonia PCP 59 Gastrointestinal Disorders 59 Valvular 59 Anti Clotting Drug 59 Study Showed 59 Systematic Review 59 Increased Mortality 59 Diabetic Foot Ulcers 59 achieved CCyR 59 Castration Resistant Prostate Cancer 59 Menopausal Women 59 Stent Thrombosis 59 novel VDA molecule 59 Shows Promise 59 Nesiritide 59 Helps Relieve 59 Reperfusion Injury 59 RNAi Therapeutic 59 Rotavirus Vaccine 59 Rheumatoid 59 Etanercept 59 Oral Interferon 59 PREGNANT PROCHIEVE ® 59 Cholinesterase Inhibitors 59 Enrolling Patients 59 HCV Protease Inhibitor 59 Node Positive 59 Guidelines Issued 59 Anthrax Toxin 59 Ranolazine 59 complement inhibitor eculizumab 59 Endothelial Function 59 Tardive Dyskinesia 59 Insulin Resistance 59 protein tyrosine phosphatase 1B 59 infections sensory neuropathy 59 Cimzia ® certolizumab pegol 59 Antibiotic Treatment 59 Nephropathy 59 Advanced Renal Cell 59 Benign Prostatic Hyperplasia BPH 59 mGluR2 positive 59 Neuroprotective Effects 59 Begins Dosing 59 hyperplasia BPH 59 Coronary Arteries 59 Spectrum Pharmaceuticals Announces 59 Is Well Tolerated 59 Collaborators Present 59 Bone Mineral Density 59 Immunotherapeutic 59 morphometric vertebral fractures 59 Phase IIa Clinical Trial 59 Nonalcoholic Steatohepatitis 59 Radiofrequency Ablation 59 Novel Mechanism 59 Phase 2b Study 59 Minimally Invasive Treatment 59 HeFH 59 arthralgias 59 Telaprevir VX 59 erythematosus 59 Tramiprosate ALZHEMED TM 59 pathologic myopia 59 Significantly Reduced 59 Mg Usa 59 multicenter multinational 59 Multiple Myeloma Patients 59 Granted Orphan Drug 59 Cell Lymphoma 59 J Am Coll 59 Mouse Models 59 Novel Therapies 59 Atherosclerotic 59 Disease Modifying 59 Mylan Receives Approval 59 delivers fluocinolone acetonide FA 59 CNS Disorders 59 Basal Cell 59 Multicenter 59 Peptic Ulcer 59 Increased Risk 59 receiving XGEVA 59 Albuferon TM 59 Acute Migraine 59 Obese Patients 59 Postherpetic Neuralgia 59 Lamotrigine 59 Eluting Stent 59 Phase III Clinical Trials 59 Myelodysplastic Syndrome MDS 59 sorafenib tablets 59 Diabetic Macular Edema DME 59 Synta Announces 59 eosinophilic asthma 59 severe hepatomegaly 59 Functional Outcomes 59 Panic Disorder 59 polyneuropathy HIV DSP 59 Trandolapril 59 Hepatotoxicity 59 de novo kidney transplant 59 Overactive Bladder OAB 59 Dupuytren Disease 59 estrogen receptor beta agonist 59 Primary Hypercholesterolemia 59 Tumor Targeting 59 Expanded Indication 59 AA Amyloidosis 59 Strongly Linked 59 Therapeutic Targets 59 Major Depressive Disorder 59 oral dual endothelin 59 Ovarian Cancer Patients 59 Endocarditis 59 Left Ventricular 59 Treatment Naive Patients 59 Uterine Fibroids 59 Osteoporosis Drug 59 Therapeutic Vaccine 59 Gene Variants 59 Ribavirin causes 59 Restless Legs Syndrome RLS 59 Metabolic Disorder 59 Gout Drug 59 Pregnancy Linked 59 Bulimia Nervosa 59 Metastases 59 invasive candidiasis 59 miconazole Lauriad ® 59 DIRECT Trial 59 Statin Drugs 59 recurrent glioblastoma multiforme 59 Squamous Cell Carcinoma 59 Chemotherapy Induced 59 Leber Hereditary Optic Neuropathy 59 Antidepressant Use 59 Therapy Reduces 59 Present Preclinical Data 59 included neutropenia anemia 59 J Am Acad 59 Acute Attacks 59 Stable Coronary Artery 59 Replacement Therapy 59 Efficacious 59 Biogen Genentech 59 induced macular edema 59 post herpetic 59 progressive dyspnea 59 Placebo Controlled Study 59 Kinase Inhibitor 59 Acute Bacterial Skin 59 BARACLUDE R 59 Psoriatic Arthritis 59 Aortic Stenosis 59 Lanthanum Carbonate 59 Vicriviroc 59 Radiation Induced 59 Suppresses 59 Prostate Tumors 59 Circulation Chronic Digestive 59 Blood Pressure Drug 59 Patent Covering 59 Non Invasive Treatment 59 humanized interleukin 6 59 Hypogonadism 59 kidney urologic 59 Cardiogenic Shock 59 Sustained Efficacy 59 severe obstructive pulmonary 59 Syncria R 59 Autologous Stem Cell Transplantation 59 Newly Diagnosed Multiple Myeloma 59 Diagnosis Treatment 59 Lung Cancer Trial 59 myoclonus 59 systemic juvenile idiopathic 59 R Saizen R 59 equine osteoarthritis 59 Suffer Depression 59 occlusion CRVO 59 Hematological 59 Spinal Fusion 59 mitoxantrone plus 59 Genes Associated 59 Infarct 59 Respiratory Syncytial Virus 59 ACE Inhibitors 59 Cardiovascular Mortality 59 Adjuvant Therapy 59 Critically Ill Patients 59 dizziness headache nausea 59 Initiate Phase III 59 Novel Inhibitor 59 Vertebral Fractures 59 Polymerase Inhibitor 59 CIMZIA TM certolizumab pegol 59 Catheter Associated 59 Ovarian Cancers 59 Colorectal Cancer Patients 58 Asthma COPD 58 LymphoStat B belimumab 58 Namenda Memantine HCl 58 Endovascular Treatment 58 Preclinical Evaluation 58 Pivotal Trial 58 Anti Tumor 58 Epstein Barr Virus 58 Aortic Aneurysm 58 ankylosing spondylitis AS 58 Novel Vaccine 58 chronic myocardial ischemia 58 Phase 2a Study 58 STRIDE PD 58 Artery Disease 58 Premature Aging 58 Acute Coronary Syndrome 58 Frozen Shoulder Syndrome 58 nausea respiratory distress 58 VICTOR E3 58 #mg BID [001] 58 Emerging Therapies 58 Osteoporosis Treatment 58 Shows Statistically Significant 58 Sleep Disordered Breathing 58 Blood Clots 58 Sustained Reduction 58 Detrol Detrol LA 58 Left Ventricular Dysfunction 58 Heterozygous Familial Hypercholesterolemia 58 Dose Ranging Study 58 #-# Full Text 58 PRODUCT SALES 58 Neurogenic 58 AVONEX ® 58 Pharmacokinetic Study 58 Urinary Incontinence 58 Infarction 58 THERAPY FOR 58 TUMORS 58 Recurrent Breast Cancer 58 Precancerous 58 Therapeutic Effects 58 BioElectronics Announces 58 Dyslipidemia 58 Solazed TM 58 targeting miR 58 Neurodegenerative 58 Mucositis 58 Fibromyalgia Syndrome 58 opioid induced 58 T Lymphocyte 58 somnolence fatigue 58 Peginterferon 58 Presents Positive 58 Kidney Transplant Patients 58 neutropenia thrombocytopenia 58 Score TOS 58 Bucindolol Based 58 5q MDS 58 Presents Preclinical Data 58 Healthbeat Report 58 developing Bicifadine serotonin 58 Preclinical Efficacy 58 Vitrasert ® 58 Dose Escalation 58 Demyelinating 58 PDGFR B 58 diarrhea vomiting rash 58 Dementia Related Psychosis 58 Tezampanel 58 ST Elevation Acute 58 Injection Site 58 lexidronam injection 58 Impairs 58 Initiates Phase II 58 Tumor Necrosis Factor 58 HEART FAILURE 58 Bipolar Depression 58 Genetic Variation 58 Experimental Vaccine 58 Epileptic Seizures 58 TB Vaccine 58 Randomized Phase II 58 Multicenter Phase 58 Low Density Lipoprotein Cholesterol 58 Microalbuminuria 58 Hepatocellular 58 subarachnoid hemorrhage SAH 58 Autoimmune Disorders 58 IND Filing 58 castrate resistant prostate cancer 58 SABER ™ 58 Induces 58 Bucindolol 58 Synaptic Plasticity 58 Hepatitis C Treatment 58 Antitumor activity 58 sJIA 58 Acute Bacterial Sinusitis ABS 58 Aggressive Reduction 58 Neurogenic Orthostatic Hypotension 58 psoriatic arthritis PsA 58 Researchers Identify 58 somatostatin analog 58 Melphalan 58 Epilepsy Drugs 58 urticaria hives 58 BCG refractory carcinoma 58 evaluating picoplatin 58 Ozarelix 58 INCB# [003] 58 Chemotherapy induced 58 vaginal candidiasis 58 receiving INTRON 58 acute porphyria 58 Phospholipase A2 58 PEGylated Fab fragment 58 Gene Variation 58 Adenoma 58 idiopathic Parkinson disease 58 Prostate Cancer Vaccine 58 Streptococcus pneumoniae Haemophilus influenzae 58 Novel Antibiotic 58 Randomized Clinical Trial 58 Study Shows Promise 58 cause cardiac channelopathies 58 Radical Prostatectomy 58 chronic myeloid 58 Bipolar Mania 58 ulcerative colitis Crohn disease 58 LENALIDOMIDE 58 Preclinical Models 58 Prognostic Factors 58 Acute Heart Failure 58 Laryngeal Cancer 58 ORLive Presents 58 Peritonitis 58 Diabetic Ulcers 58 Elotuzumab 58 Acute Myocardial 58 Neuroendocrine Tumors 58 Osteoarthritis Patients 58 retinal vein occlusion 58 Growth Hormone Deficiency 58 aplastic anemia AA 58 By Phillip Ramati 58 Disease IBD 58 Betaferon R 58 IIa Clinical Trial 58 Brentuximab Vedotin SGN 58 Carboplatin Paclitaxel 58 Reimbursement Issues 58 Zoledronic Acid 58 Hip Fractures 58 subsyndromal 58 Cholesterol Levels 58 IBS C 58 dyslipidemia hypertension diabetes 58 Antitumor 58 Candidiasis 58 Decitabine 58 PLX STROKE targeting 58 IE INFECTED AND 58 Depressive Symptoms 58 Ankylosing spondylitis 58 syndrome gastroesophageal reflux 58 Long Term Survival 58 Contrast Agent 58 Suicidality 58 Inhibitory 58 vomiting constipation 58 Exacerbations 58 Oral Insulin 58 Arterial Disease 58 Ultrasensitive 58 Hematological Cancers 58 anaphylactic reactions bronchospasm 58 Vaginal Gel 58 Paclitaxel Carboplatin 58 Anticancer Activity 58 neuropathic pain spasticity 58 Claudication 58 Tolvaptan 58 Breast Cancer Patients 58 Demonstrates Potent 58 jaundice fatigue 58 Vitamin D Linked 58 Drug Combinations 58 PHPT 58 FDA Approvals 58 Coronary Artery Bypass Graft 58 Lowers Blood Pressure 58 FDA Okays 58 Liver Cirrhosis 58 Skin Structure Infections ABSSSI 58 Treating Depression 58 Erythropoietic therapies may 58 Sipuleucel T 58 sitagliptin metformin 58 Vildagliptin 58 C1 Inhibitor 58 Lung Function 58 Nucleoside 58 Tipranavir 58 Namenda ® 58 Prenatal Exposure 58 Prevent Stroke 58 adrenocortical cancer 58 Holds Promise 58 Brain Shrinkage 58 AVAPRO 58 SYMPTOMS 58 Eases Pain 58 Tasigna prolongs 58 Oral Cladribine 58 Causes Symptoms 58 subependymal giant cell 58 allosteric modulator PAM 58 RhuDex R 58 Rare Genetic 58 Immune Cells 58 Data Indicate 58 Acute Coronary Syndromes ACS 58 Peginterferon Alfa 2b 58 Stress Urinary Incontinence 58 Orthop Surg 58 Immune Mediated 58 Follicular Lymphoma 58 ergot derivatives 58 Parathyroid Hormone 58 Visceral Fat 58 Correlates 58 heartburn nausea 58 Carcinoid Syndrome 58 antibody MAb 58 Initiates Phase 2b 58 Exercise Reduces 58 Genital Herpes 58 Neuropathic 58 Social Anxiety Disorder 58 Menstrual Cramps 58 NDA Submission 58 Abstract Accepted 58 Study Examines 58 Corneal Transplant 58 Progressive Multifocal Leukoencephalopathy 58 dizziness numbness 58 Wafer polifeprosan